Turtle Creek Wealth Advisors, LLC

Position in PRME — Prime Medicine, Inc.

CIK 2007171 DALLAS, TX

Position in PRME

as of Mar 31, 2026 · filed Apr 27, 2026 Compact

Position Value

$87,000

-$51,500 QoQ

Shares Held

25,000

0.0% QoQ

Ownership

0.014%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2025

2 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Turtle Creek Wealth Advisors, LLC holds $1,515,097 across 4 Biotechnology names. PRME ranks #4 (5.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MDXG	Mimedx Group, Inc.	166,700	$658,465
2	VRTX	Vertex Pharmaceuticals Inc / Ma	938	$418,854
3	REGN	Regeneron Pharmaceuticals, Inc.	454	$350,778
4	PRME	Prime Medicine, Inc. This page	25,000	$87,000

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$87,000	25,000	0.0%	Shares	Sole	2026-04-27
2025-09-30	$138,500	25,000	—	Shares	Sole	2025-10-29
No filing history on record for this holder in this stock.